4//SEC Filing
CURTIS GEOFFREY M. 4
Accession 0001209191-21-012408
CIK 0001492426other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:00 PM ET
Size
12.6 KB
Accession
0001209191-21-012408
Insider Transaction Report
Form 4
CURTIS GEOFFREY M.
SVP, Corporate Communications
Transactions
- Award
Ordinary Shares
2021-02-17+1,571→ 87,110 total - Tax Payment
Ordinary Shares
2021-02-17$87.17/sh−696$60,670→ 86,414 total - Award
Performance Restricted Stock Units (PSUs)
2021-02-17+3,144→ 3,144 total→ Ordinary Shares (3,144 underlying) - Award
Performance Restricted Stock Units (PSUs)
2021-02-17+11,610→ 11,610 total→ Ordinary Shares (11,610 underlying)
Holdings
- 420(indirect: By Spouse)
Ordinary Shares
Footnotes (3)
- [F1]On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above. The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023.
- [F2]Each PSU represents a contingent right to receive one ordinary share of the Issuer.
- [F3]On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001667903
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:00 PM ET
- Size
- 12.6 KB